Konica Minolta (4902) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
13 Jun, 2025Executive summary
Revenue for the first half rose 5.6% year-over-year to ¥583.7 billion, driven by growth across all regions and segments, aided by yen depreciation and strong office and professional print segments.
Business contribution profit surged to ¥17.8 billion (up 679.4% YoY), but an operating loss of ¥0.7 billion was recorded due to ¥16.4 billion in global structural reform expenses and costs related to ending production at a Chinese subsidiary.
Net loss attributable to owners widened to ¥10.7 billion, impacted by foreign exchange losses and high tax expenses, with basic EPS at -¥21.66.
Precision Medicine Business is being divested, with Ambry Genetics to be sold for $600 million, and the segment to be classified as discontinued from Q3 FY2024.
Progress in global structural reform and business selection ahead of schedule, including ending production at a Wuxi subsidiary and transferring Ambry Genetics.
Financial highlights
FY24 6M revenue rose 5.6% year-over-year to ¥583.7 billion; gross profit up 9.9% to ¥260.6 billion.
Business contribution profit surged to ¥17.8 billion (up ¥15.5 billion YoY); free cash flow improved to ¥16.7 billion.
Net loss attributable to owners widened to ¥10.7 billion, impacted by foreign exchange losses and high tax expenses.
Gross profit ratio improved to 44.7% (up 1.7pt YoY); business contribution profit ratio at 3.1% (up 2.6pt YoY).
Operating profit impacted by ¥16.4 billion in structural reform expenses.
Outlook and guidance
FY24 revenue forecast revised down to ¥1,134.0 billion (from ¥1,160.0 billion); business contribution profit forecast at ¥42.0 billion.
Operating profit forecast revised to -¥14.0 billion, reflecting impairment risks and restructuring costs.
Net profit guidance unchanged, incorporating a ¥41.0 billion gain from Ambry Genetics share transfer.
Dividend forecast remains at zero for FY24, with resumption targeted for FY25 as profit recovers.
Profit attributable to owners and basic EPS forecasted at zero, reflecting the impact of discontinued operations.
Latest events from Konica Minolta
- Operating profit rebounded sharply and outlook was raised, despite lower revenue.4902
Q3 20265 Feb 2026 - Operating profit surged to ¥23.0B despite 8% revenue drop, led by cost reforms and segment gains.4902
Q2 20265 Nov 2025 - Profit and margins improved despite revenue drop, cost cuts, and tariff and currency headwinds.4902
Q1 202631 Jul 2025 - Revenue up 7.4% year-over-year, with improved profits and all segments growing.4902
Q1 202513 Jun 2025 - Impairments drove a sharp loss, but profit recovery and higher dividends are forecast.4902
Q4 20256 Jun 2025 - Profit growth outweighed by impairment losses and restructuring, with outlook unchanged.4902
Q3 20255 Jun 2025